blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1137662

EP1137662 - PHARMACEUTICAL COMPOSITIONS COMPRISING QUINAPRIL MAGNESIUM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  15.07.2005
Database last updated on 03.10.2024
Most recent event   Tooltip28.03.2008Lapse of the patent in a contracting state
New state(s): PT
published on 30.04.2008  [2008/18]
Applicant(s)For all designated states
SHERMAN, Bernard Charles
50 Old Colony Road Willowdale
Ontario M2L 2K1 / CA
[N/P]
Former [2001/40]For all designated states
SHERMAN, Bernard Charles
50 Old Colony Road
Willowdale, Ontario M2L 2K1 / CA
Inventor(s)01 / see applicant
...
 [2001/40]
Representative(s)Howard, Paul Nicholas, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2001/40]Howard, Paul Nicholas, et al
Carpmaels & Ransford 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date99957805.707.12.1999
[2001/40]
WO1999CA01169
Priority number, dateNZ1998033320608.12.1998         Original published format: NZ 33320698
[2001/40]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0034314
Date:15.06.2000
Language:EN
[2000/24]
Type: A1 Application with search report 
No.:EP1137662
Date:04.10.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 15.06.2000 takes the place of the publication of the European patent application.
[2001/40]
Type: B1 Patent specification 
No.:EP1137662
Date:08.09.2004
Language:EN
[2004/37]
Search report(s)International search report - published on:EP15.06.2000
ClassificationIPC:C07K5/062, A61K38/05, A61P9/12
[2001/40]
CPC:
A61K38/05 (EP,US); A61K31/47 (KR); A61P43/00 (EP);
A61P9/12 (EP); C07K5/06078 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/40]
TitleGerman:QUINAPRIL MAGNESIUM ENTHALTENDE, PHARMAZEUTISCH WIRKSAME ZUSAMMENSETZUNG[2001/40]
English:PHARMACEUTICAL COMPOSITIONS COMPRISING QUINAPRIL MAGNESIUM[2001/40]
French:COMPOSITIONS PHARMACEUTIQUES CONTENANT DU QUINAPRIL MAGNESIUM[2004/05]
Former [2001/40]COMPOSITIONS PHARMACEUTIQUES CONTENANT QUINAPRIL MAGNESIUM
Entry into regional phase13.06.2001National basic fee paid 
13.06.2001Designation fee(s) paid 
13.06.2001Examination fee paid 
Examination procedure27.06.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
13.06.2001Amendment by applicant (claims and/or description)
13.06.2001Examination requested  [2001/40]
01.07.2002Observations by third parties
17.07.2003Despatch of a communication from the examining division (Time limit: M04)
14.11.2003Reply to a communication from the examining division
20.02.2004Communication of intention to grant the patent
24.06.2004Fee for grant paid
24.06.2004Fee for publishing/printing paid
Opposition(s)09.06.2005No opposition filed within time limit [2005/35]
Fees paidRenewal fee
13.06.2001Renewal fee patent year 03
12.12.2002Renewal fee patent year 04
12.12.2003Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT08.09.2004
BE08.09.2004
CH08.09.2004
CY08.09.2004
FI08.09.2004
LI08.09.2004
NL08.09.2004
IE07.12.2004
LU07.12.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
MC31.12.2004
PT08.02.2005
[2008/18]
Former [2007/23]AT08.09.2004
BE08.09.2004
CH08.09.2004
CY08.09.2004
FI08.09.2004
LI08.09.2004
NL08.09.2004
IE07.12.2004
LU07.12.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
MC31.12.2004
Former [2006/13]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
NL08.09.2004
IE07.12.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
MC31.12.2004
Former [2005/46]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
DK08.12.2004
GR08.12.2004
SE08.12.2004
MC31.12.2004
Former [2005/45]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
GR08.12.2004
SE08.12.2004
MC31.12.2004
Former [2005/28]AT08.09.2004
BE08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
GR08.12.2004
SE08.12.2004
Former [2005/21]AT08.09.2004
CH08.09.2004
FI08.09.2004
LI08.09.2004
GR08.12.2004
SE08.12.2004
Former [2005/18]AT08.09.2004
FI08.09.2004
GR08.12.2004
SE08.12.2004
Former [2005/13]AT08.09.2004
FI08.09.2004
SE08.12.2004
Former [2005/11]FI08.09.2004
SE08.12.2004
Former [2005/10]SE08.12.2004
Cited inInternational search[X]US4743450  (HARRIS MICHAEL [US], et al) [X] 1-20 * column 2, line 11 - line 34 * * column 3, line 25 - line 39; example -; claim - *;
 [A]US5573780  (SHERMAN BERNARD C [CA]) [A] 1-19 * example -; claim - *;
 [A]US5690962  (SHERMAN BERNARD CHARLES [CA]) [A] 1-19* example -; claim - *;
 [E]WO9962560  (WARNER LAMBERT CO [US], et al) [E] 1,20 * page 6, line 6 - line 14 * * page 8, line 6 - page 9, line 17; example 3; claim - *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.